Medicare Enrolled
Dr. Kuldip Behniwal, M.D.
Urology Physician · Fresno, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Behniwal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Behniwal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Behniwal
Dr. Kuldip Behniwal is an urology physician in Fresno, CA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Behniwal performed 39,288 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Behniwal received a total of $7,780 from 47 pharmaceutical and/or device companies across 247 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Behniwal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 5% volume in CA
$7,780 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗39,288
Medicare services
Top 5% in CA for urology physician
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
26,000 | $0 | $0 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
4,400 | $0 | $0 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,870 | $2 | $6 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,548 | $66 | $190 |
| BCG treatment for bladder cancer | 1,301 | $2 | $10 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
1,213 | $8 | $66 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
547 | $8 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
295 | $101 | $270 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 269 | $135 | $458 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
225 | $12 | $44 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
222 | $200 | $529 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
217 | $125 | $350 |
| Injection, tobramycin sulfate, up to 80 mg | 201 | $2 | $12 |
| Cell examination of specimen, concentration technique A laboratory test that uses a concentration technique to examine cells from a specimen. |
114 | $35 | $135 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
98 | $29 | $75 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
95 | $24 | $58 |
| X-ray of body plane An X-ray imaging test that captures a specific plane or section of the body to visualize internal structures. |
93 | $73 | $196 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
92 | $6 | $43 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
88 | $0 | $2 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
80 | $0 | $2 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
45 | $104 | $400 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
42 | $306 | $760 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
32 | $74 | $186 |
| Simple measurement of urine flow pressure in bladder A test that measures the pressure of urine flow within the bladder. This procedure assesses bladder function by recording pressure changes during urination. |
32 | $184 | $499 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
31 | $85 | $245 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
26 | $297 | $805 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
25 | $51 | $137 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
21 | $27 | $184 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
21 | $167 | $432 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
19 | $301 | $848 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
13 | $275 | $712 |
| Prostate tissue destruction using radiofrequency heated water vapor A procedure that destroys prostate tissue by using radiofrequency energy to heat water vapor. This method is applied to treat the prostate gland. |
13 | $1,453 | $3,950 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$7,780
Total received (2018-2024)
Avg $1,111/year across 7 years
Top 25% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
247
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,132
2023
$1,272
2022
$603
2021
$355
2020
$178
2019
$1,052
2018
$2,189
Payments by company (2024)
Teleflex LLC
$1,197
Janssen Biotech, Inc.
$376
Sumitomo Pharma America, Inc.
$74
Ferring Pharmaceuticals Inc.
$74
Boston Scientific Corporation
$69
COLOPLAST CORP
$50
Olympus America Inc.
$44
ABBVIE INC.
$30
Laborie Medical Technologies Corp.
$30
Novartis Pharmaceuticals Corporation
$29
Tempus AI, Inc
$28
PROGENICS PHARMACEUTICALS, INC.
$24
UROGEN PHARMA, INC.
$24
Dendreon Pharmaceuticals LLC
$23
PFIZER INC.
$22
IMMUNITYBIO, INC.
$20
ACCORD HEALTHCARE, INC.
$17
Top 3 companies account for 77.3% of 2024 payments
All-time payments by company (2018-2024) ›
Teleflex LLC
$1,703
Janssen Biotech, Inc.
$872
Astellas Pharma US Inc
$819
Coloplast Corp
$604
Boston Scientific Corporation
$489
NeoTract Inc.
$338
Avadel Specialty Pharmaceuticals, LLC
$268
AbbVie, Inc.
$242
Dendreon Pharmaceuticals LLC
$163
Amgen Inc.
$146
Sumitomo Pharma America, Inc.
$140
Medtronic USA, Inc.
$132
PFIZER INC.
$125
Olympus America Inc.
$117
BOSTON SCIENTIFIC CORPORATION
$115
Myovant Sciences Inc.
$105
Supernus Pharmaceuticals, Inc.
$103
Ferring Pharmaceuticals Inc.
$100
Janssen Products, LP
$100
Janssen Scientific Affairs, LLC
$95
Allergan Inc.
$90
COLOPLAST CORP
$83
AstraZeneca Pharmaceuticals LP
$77
TOLMAR Pharmaceuticals, Inc.
$72
UROVANT SCIENCES INC
$61
Novartis Pharmaceuticals Corporation
$52
Merck Sharp & Dohme LLC
$44
Bayer HealthCare Pharmaceuticals Inc.
$44
Antares Pharma, Inc.
$44
ACCORD HEALTHCARE, INC.
$43
Endo Pharmaceuticals Inc.
$35
ABBVIE INC.
$30
Laborie Medical Technologies Corp.
$30
Progenics Pharmaceuticals, Inc.
$28
Tempus AI, Inc
$28
Janssen Pharmaceuticals, Inc
$26
Duchesnay USA Incorporated
$25
PROGENICS PHARMACEUTICALS, INC.
$24
Accord Healthcare, Inc.
$24
UROGEN PHARMA, INC.
$24
NxThera, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$21
IMMUNITYBIO, INC.
$20
PROCEPT BioRobotics Corporation
$18
MEDIVATION FIELD SOLUTIONS LLC
$16
Allergan, Inc.
$12
Blue Earth Diagnostics Limited
$11
Top 3 companies account for 43.6% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AFINITOR · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · ARIS · Altis · Androgel · Aris · Axumin · BOTOX · CAMCEVI · Coloplast TFL Drive · EDEX · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · GENERAL BPH · GENERAL - BPH · GENERAL BPH · INTERSTIM ICON · JELMYTO · KEYTRUDA · Kerendia · LYNPARZA · LithoVue · Lupron · MYRBETRIQ · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · Osphena · PLUVICTO · PROVENGE · PVC · PYLARIFY · Rezum · SOLYX · SpaceOAR VUE System - 10mL · SpeediCath · TITAN · Titan · UROLIFT · UroLift · UroLift System · VIRTUE · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
18
County median income
$71,434
Nearest hospital to ZIP centroid (approximate)
SAINT AGNES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Behniwal is a mixed practice specialist, with above-average Medicare volume (top 5% in CA), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Behniwal experienced with testosterone injection?
Based on Medicare claims data, Dr. Behniwal performed 26,000 testosterone injection services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Behniwal receive payments from pharmaceutical companies?
Yes. Dr. Behniwal received a total of $7,780 from 47 companies across 247 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Behniwal's costs compare to other urology physicians in Fresno?
Dr. Behniwal's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Behniwal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Fresno
Browse urology physicians in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology